Determination of the Cannabinoid CB1 Receptor’s Positive Allosteric Modulator Binding Site through Mutagenesis Studies

Positive allosteric modulators (PAMs) of the cannabinoid CB1 receptor (CB<sub>1</sub>) offer potential therapeutic advantages in the treatment of neuropathic pain and addiction by avoiding the adverse effects associated with orthosteric CB<sub>1</sub> activation. Here, molecu...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: Hayley M. Green, Daniel M. J. Fellner, David B. Finlay, Daniel P. Furkert, Michelle Glass
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Subjects:
Cannabinoid CB1 receptor
allosteric modulation
allosteric agonism
GAT229
GAT228
ZCZ011
Online Access:https://www.mdpi.com/1424-8247/17/2/154

Internet

https://www.mdpi.com/1424-8247/17/2/154

Similar Items